| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Haruo Hanyu, Soichiro Shimizu, Yuriko Tanaka, Hidekazu Kanetaka, Toshihiko Iwamoto, Kimihiko Ab. Differences in magnetization transfer ratios of the hippocampus between dementia with Lewy bodies and Alzheimer's disease. Neuroscience letters. vol 380. issue 1-2. 2005-07-28. PMID:15854771. |
we compared magnetization transfer ratios (mtrs) in the brains of patients with dementia with lewy bodies (dlb) and alzheimer's disease (ad) to determine whether regional differences in the brain structures between dlb and ad are detectable with magnetization transfer imaging. |
2005-07-28 |
2023-08-12 |
human |
| Hideo Mor. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD. Parkinsonism & related disorders. vol 11 Suppl 1. 2005-07-25. PMID:15885628. |
pathological substrate of dementia in parkinson's disease--its relation to dlb and dlbd. |
2005-07-25 |
2023-08-12 |
Not clear |
| Hideo Mor. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD. Parkinsonism & related disorders. vol 11 Suppl 1. 2005-07-25. PMID:15885628. |
this pathological change corresponds to the neocortical type, which was originally reported as diffuse lewy body disease (dlbd), or a transitional type of dementia with lewy bodies (dlb). |
2005-07-25 |
2023-08-12 |
Not clear |
| Yoshio Tsuboi, Dennis W Dickso. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different? Parkinsonism & related disorders. vol 11 Suppl 1. 2005-07-25. PMID:15885629. |
the relationship of dementia with lewy bodies (dlb) and parkinson's disease with dementia (pdd) is debated. |
2005-07-25 |
2023-08-12 |
Not clear |
| Yoshio Tsuboi, Dennis W Dickso. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different? Parkinsonism & related disorders. vol 11 Suppl 1. 2005-07-25. PMID:15885629. |
in dlb, dementia antedates parkinsonism; in pdd, parkinsonism antedates dementia. |
2005-07-25 |
2023-08-12 |
Not clear |
| Dhiren Sing. Diagnosis of dementia with Lewy bodies in clinical practice: a literature review. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. vol 13. issue 1. 2005-07-19. PMID:15777413. |
to review the research data about dementia with lewy bodies (dlb) and describe those clinical features and investigations that will enhance more accurate diagnosis in day-to-day practice. |
2005-07-19 |
2023-08-12 |
Not clear |
| M Bozzali, A Falini, M Cercignani, F Baglio, E Farina, M Alberoni, P Vezzulli, F Olivotto, F Mantovani, T Shallice, G Scotti, N Canal, R Nemn. Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study. Brain : a journal of neurology. vol 128. issue Pt 7. 2005-07-18. PMID:15817515. |
the aim of the present study was to apply diffusion tensor mri (dt-mri), a quantitative mri measure which reflects tissue organization, to dementia with lewy bodies (dlb). |
2005-07-18 |
2023-08-12 |
Not clear |
| Dag Aarsland, Robert Perry, Jan P Larsen, Ian G McKeith, John T O'Brien, Elaine K Perry, David Burn, Clive G Ballar. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. The Journal of clinical psychiatry. vol 66. issue 5. 2005-07-11. PMID:15889951. |
severe sensitivity to neuroleptic agents is a major clinical problem in dementia with lewy bodies (dlb), but has not been determined in parkinson's disease (pd) and pd with dementia (pdd). |
2005-07-11 |
2023-08-12 |
Not clear |
| Brit Mollenhauer, Lukas Cepek, Mirko Bibl, Jens Wiltfang, Walter J Schulz-Schaeffer, Barbara Ciesielczyk, Manuela Neumann, Petra Steinacker, Hans A Kretzschmar, Sigrid Poser, Claudia Trenkwalder, Markus Ott. Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies. Dementia and geriatric cognitive disorders. vol 19. issue 2-3. 2005-06-24. PMID:15637452. |
the intra vitam diagnosis of dementia with lewy bodies (dlb) is still based on clinical grounds. |
2005-06-24 |
2023-08-12 |
Not clear |
| Moussa B H Youdim, Mati Fridkin, Hailin Zhen. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. Mechanisms of ageing and development. vol 126. issue 2. 2005-06-13. PMID:15621213. |
degeneration of nigrostriatal dopamine neurons and cholinergic cortical neurones are the main pathological features of parkinson's disease (pd) and for the cognitive deficit in dementia of the alzheimer' type (ad) and in dementia with lewy bodies (dlb), respectively. |
2005-06-13 |
2023-08-12 |
mouse |
| Moussa B H Youdim, Mati Fridkin, Hailin Zhen. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. Mechanisms of ageing and development. vol 126. issue 2. 2005-06-13. PMID:15621213. |
many pd and dlb subjects have dementia and depression resulting from possible degeneration of cholinergic and noradrenergic and serotonergic neurons. |
2005-06-13 |
2023-08-12 |
mouse |
| Moussa B H Youdim, Mati Fridkin, Hailin Zhen. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. Mechanisms of ageing and development. vol 126. issue 2. 2005-06-13. PMID:15621213. |
ladostigil (tv-3326, n-propargyl-3r-aminoindan-5yl)-ethyl methylcarbamate), has both che and mao-ab inhibitory activity, as potential treatment of ad and dlb or pd subjects with dementia being a brain selective mao-ab inhibitor it has limited potentiation of the pressor response to oral tyramine and exhibits antidepressant activity similar to classical non-selective mao inhibitor antidepressants by increasing brain serotonin and noradrenaline. |
2005-06-13 |
2023-08-12 |
mouse |
| T Nakajima, S Takauchi, K Ohara, M Kokai, R Nishii, S Maeda, A Takanaga, T Tanaka, M Takeda, M Seki, Y Morit. Alpha-synuclein-positive structures induced in leupeptin-infused rats. Brain research. vol 1040. issue 1-2. 2005-06-07. PMID:15804428. |
abnormal accumulation of alpha-synuclein is regarded as a key pathological step in a wide range of neurodegenerative processes, not only in parkinson's disease (pd) and dementia with lewy bodies (dlb) but also in multiple-system atrophy (msa). |
2005-06-07 |
2023-08-12 |
human |
| Edward Rockenstein, Gert Schwach, Elisabeth Ingolic, Anthony Adame, Leslie Crews, Michael Mante, Roswitha Pfragner, Edith Schreiner, Manfred Windisch, Eliezer Maslia. Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein. Journal of neuroscience research. vol 80. issue 2. 2005-06-02. PMID:15765523. |
disorders with lewy body (lb) formation, such as parkinson's disease (pd) and dementia with lewy bodies (dlb), are characterized by alpha-synuclein accumulation in the neuronal cell body. |
2005-06-02 |
2023-08-12 |
mouse |
| R Sakakibara, T Ito, T Uchiyama, M Asahina, Z Liu, T Yamamoto, Y Yamanaka, T Hattor. Lower urinary tract function in dementia of Lewy body type. Journal of neurology, neurosurgery, and psychiatry. vol 76. issue 5. 2005-05-31. PMID:15834036. |
dementia of lewy body (dlb) type is the second commonest degenerative cause of dementia and autonomic dysfunction has been recognised in dlb. |
2005-05-31 |
2023-08-12 |
Not clear |
| Carolina Serrano, Diego García-Borreguer. Fluctuations in cognition and alertness in Parkinson's disease and dementia. Neurology. vol 63. issue 8 Suppl 3. 2005-05-24. PMID:15505141. |
fluctuations in cognition and alertness (fc/fa) are key manifestations of dementia with lewy bodies (dlb) and also have been recognized recently in patients with parkinson's disease (pd) with dementia, a condition that shares important clinical, genetic, and neuropathologic characteristics with dlb. |
2005-05-24 |
2023-08-12 |
Not clear |
| I S Preobrazhenskaia, E A Mkhitarian, N N Iakhn. [A comparative analysis of cognitive disturbances in dementia with Levy's bodies and Alzheimer's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 105. issue 1. 2005-05-24. PMID:15704478. |
basing on a neuropsychological study of 50 patients with dementia with levy's bodies (dlb) and 50 patients with alzheimer's disease (ad), peculiarities of cognitive impairment in these diseases are discussed. |
2005-05-24 |
2023-08-12 |
Not clear |
| N N Koberskaia, L R Zenkov, V V Zakharov, I S Preobrazhenskai. [Cognitive potential P300 in dementia with Levy's bodies and Alzheimer's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 105. issue 1. 2005-05-24. PMID:15704487. |
neurodegenerative diseases accompanied by cognitive impairment (dementia with levy's bodies--dlb and alzheimer's disease--ad) and others) are becoming more widespread due to increasing population life expectancy. |
2005-05-24 |
2023-08-12 |
Not clear |
| Horacio Kaufmann, Kirsty Nahm, Dushyant Purohit, David Wolf. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology. vol 63. issue 6. 2005-05-18. PMID:15452307. |
the authors report the clinical and postmortem neuropathologic findings of two patients, one with parkinson disease (pd) and one with dementia with lewy bodies (dlb), both of whom initially sought treatment for isolated autonomic failure. |
2005-05-18 |
2023-08-12 |
Not clear |
| Makoto Hashimoto, Kohichi Kawahara, Pazit Bar-On, Edward Rockenstein, Leslie Crews, Eliezer Maslia. The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease. Journal of molecular neuroscience : MN. vol 24. issue 3. 2005-05-11. PMID:15655259. |
parkinson's disease (pd) and dementia with lewy bodies (dlb) are members of a family of disorders characterized by the presence of inclusion bodies, or lewy bodies (lbs), filled with aggregates of alpha-synuclein. |
2005-05-11 |
2023-08-12 |
Not clear |